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Hyperkalemia is among the most common electrolyte
imbalances encountered in clinical practice, affecting up to
8% of hospitalized patients in the United States.1 The most
common causes are renal disease (encountered in 75% of
patients with severe hyperkalemia) and administration of
medications that elevate serum potassium levels (found in
67% of patients), including drugs often employed in
cardiovascular disease such as angiotensin-converting
enzyme inhibitors, angiotensin-receptor blockers and aldos-
terone blocking agents. Often the origin of hyperkalemia is
multifactorial and the speciﬁc cause is never deﬁned. Hyper-
kalemia is known to have signiﬁcant effects on electrical
impulse generation and propagation in the heart, with
conduction disturbances that may occur at various locations
in the specialized conduction system.
Case Presentation
We present the case of a 55-year-old male with a history of
diabetes, hypertension, and nonischemic dilated cardiomy-
opathy, status post–cardiac resynchronization therapy plus
deﬁbrillator, who was referred to the electrophysiology
laboratory for ventricular tachycardia ablation after experi-
encing recurrent implantable cardioverter-deﬁbrillator
shocks despite multiple prior ablation procedures. The
patient´s drug regimen included valsartan 80 mg twice daily,
spironolactone 25 mg once daily, sotalol 80 mg twice daily,
mexiletine 150 mg twice daily, and bumetanide 1 mg once
daily. He had chronic renal insufﬁciency with a baseline
creatinine concentration of 1.7 mg/dL. Biventricular pacing
was discontinued for the procedure, and the device was
programmed to VVI backup pacing at 40 beats per minute.
On catheter placement, a prolonged HV interval was noted
(HV 119 ms) in contrast to an HV interval of 75 ms in the
previous procedure (7 months prior); the AH interval was 99KEYWORDS Conduction; HV; Hyperkalemia; Potassium
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with an atypical right bundle branch block morphology and
right superior axis were evident in the surface electrocardio-
gram (Figures 1 and 2). The serum potassium concentration
(K) was noted to be 6.8 mEq/L. After treatment with insulin,
glucose and intravenous loop diuretics, potassium levels
were normalized (K 4.4 mEq/L), and the HV interval
decreased in parallel, to 78 ms, with concomitant reductions
in PR and QRS widths (221 ms and 183 ms, respectively)
(Figures 1 and 2). Hyperkalemia was attributed to the patient
mistakenly discontinuing loop diuretics (instead of mexile-
tine as instructed) while remaining on valsartan and spiro-
nolactone in the days leading up to the procedure. The
procedure was resumed immediately after the correction of
hyperkalemia, with induction of ventricular tachycardia that
was successfully ablated from the endocardium targeting the
basal lateral wall of the left ventricle.Discussion
Although hyperkalemia has long been known to induce
conduction disturbances at several levels,2 few documented
cases of acute reversible HV prolongation secondary to
hyperkalemia are found in the literature.3 Extracellular
potassium levels play a key role in the normal electro-
physiological function of myocytes, as the transmembrane
potassium gradient is the main determinant of resting
membrane potential. A biphasic response to hyperkalemia
has been described4 whereby mild hyperkalemia (K o 6–7
mEq/L) lowers resting membrane potential (makes it less
negative) more so than threshold potential, diminishing the
difference between the two and leading to increased excit-
ability and enhanced conduction.5 Additionally, action
potential duration is reduced because of increased potassium
conductance during phases 2 and 3 of the action potential.
These phenomena may manifest in the surface electrocardio-
gram as shortening of the PR, QRS, and QT intervals.4 With
increasing extracellular potassium levels (K4 7–8 mEq/L),
as resting membrane potential progressively becomes less
negative, the percentage of available sodium channels is
reduced, leading to a decrease in the inward sodium current
during phase 0 of the action potential and a reduction in
conduction velocity; which is evidenced by lengthening Ppen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Prior to an electrophysiological procedure,
attention should be paid to the patient’s drug
regimen. An effort should be made to adequately
relay instructions on any changes to previous
medications required for the procedure, such as
discontinuation of antiarrhythmic drugs.
 It is indispensable to carefully review the results of
the patient´s blood work, including basic blood
chemistry as well as complete blood count, before
the initiation of an electrophysiological procedure.
 Hyperkalemia can induce reversible infra-Hisian
conduction delay. In patients with underlying
conduction disease, HV prolongation may actually
occur with lower potassium levels.
Heart Rhythm Case Reports, Vol 2, No 6, November 2016460waves and prolongation of the PR and QRS intervals. As the
specialized conduction tissue is least sensitive to the effects
of hyperkalemia; impaired conduction at this level (His
bundle) should be expected to appear only at higher
extracellular potassium levels.4Figure 1 Surface electrocardiogram with serum potassium levels at 6.8 mEq/L (t
QRS (225 ms) intervals during hyperkalemia compared with normokalemia (PR 22
block morphology with a right superior axis.In our patient, infra-Hisian conduction disease was
already present at baseline (HV 75 ms 6 months prior, HV
78 ms after correction of hyperkalemia) and may have been
partly inﬂuenced by the long-term use of mexiletine (which
the patient had already been taking at the time of the previous
procedure). Nonetheless, the decrease in the HV interval
from 119 to 78 ms on normalization of potassium levels
suggest additional infra-Hisian conduction delay attributable
to hyperkalemia. Additionally, the patient’s AH interval
under hyperkalemia also appears to be longer than under
normokalemia (99 ms vs 69 ms). The AH interval duration is
characterized by marked variability due to variations in
autonomic state. In this particular case, the ﬁrst recordings
(left in Figure 2, K 6.8 mEq/L, AH 99 ms) were obtained
under deeper sedation, with the later recordings (right in
Figure 2, K 4.4 mEq/L, AH 69 ms) obtained under more-
superﬁcial sedation. These variations in the depth of sedation
likely account for any variations in AH interval.Conclusion
We describe a case of reversible HV prolongation secondary
to moderate hyperkalemia in a patient with underlying infra-
Hisian conduction disease. In patients with diseased con-op) and at 4.4 mEq/L (bottom). Note the prolongation of the PR (292 ms) and
1 ms, QRS 183 ms). QRS in both cases has an atypical right bundle branch
Figure 2 Intracardiac tracings with serum potassium levels (K) at 6.8
mEq/L (left) and 4.4 mEq/L (right). From top to bottom: surface electro-
cardiogram leads, His bundle recordings. Note the prolongation of the HV
interval (119 ms), which decreases (78 ms) on correction of hyperkalemia.
His bundle electrocardiogram is singled out with a red arrow: QRS onset
(marked by the vertical red line) is earliest in V2.
461Loughlin et al A Cause of HV Prolongationduction tissue, further decreases in impulse conduction may
become apparent at potassium levels not normally associated
with HV prolongation.
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